New York State Common Retirement Fund’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,109
Closed -$370K 3219
2024
Q3
$370K Sell
11,109
-2,800
-20% -$96.4K ﹤0.01% 2054
2024
Q2
$376K Buy
13,909
+3,933
+39% +$77.6K ﹤0.01% 2162
2024
Q1
$215K Sell
9,976
-2,057
-17% -$44.9K ﹤0.01% 2398
2023
Q4
$72.6K Sell
12,033
-22
-0.2% -$110 ﹤0.01% 2871
2023
Q3
$67K Buy
12,055
+155
+1% +$998 ﹤0.01% 2914
2023
Q2
$87.3K Buy
+11,900
New +$90.1K ﹤0.01% 2959

New York State Common Retirement Fund's LBPH Position: Q4 2024 in Review

New York State Common Retirement Fund sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 11,109 shares — an estimated $370K sold.

New York State Common Retirement Fund first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $376K in Q2 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • New York State Common Retirement Fund reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11,109 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $370K.
  • New York State Common Retirement Fund first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • New York State Common Retirement Fund's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $376K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on New York State Common Retirement Fund's 13F filing for Q4 2024, filed 31 Jan 2025.